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Cerebral necrosis after radiation theraphy for patients with 
brain metastases is being recognized as a problem more 
common than previously estimated. 
The initial goal of this project is trying to develop a diagnosis 
model with machine learning techniques to predict the onset 
of necrosis in order to improve current diagnosis. And the 
ultimate goal is to better understand the onset of necrosis, 
reduce its occurrence and generate general guides on 
radiation therapy dose value for metastases treatment. 
Abstract
Since it is a classificaiton problem, three baseline models were 
explored, including Logistics Regression, Random Forest and 
Gradient Boosting. After hyperparameter tuning , those three 
models could archieve negative log-loss of .56, .52 and .43 
respectively. 
Noticing the fact that the dataset was significantly unbalanced, 
with over 80% of patients labeling as non-necrosis, we felt the 
need to adjust the class distribution of our dataset. One 
technique was under-sampling the majority class, which was 
the patients without necrosis in this case. Another technique 
was over-sampling the minority class, which was the patients 
with necrosis.  
Introduction
Data that was utilized during this project was contributed by 
Radiation Oncology Department at UCSF Medical. It consisted 
of features of over 10,000 metastases as well as over 2,000 
patients. 
Data preprocessing included feature selection, category 
encoding and missing value imputation. The date information 
of patient surgeries was dropped and instead, patient age was 
calculated; one-hot encoding was applied to represent 
different tumor primary sites;  and since most of the 
numerical inputs are boolean or discrete, missing values were 
imputed by mode. 
Data Available
In this project, the explored re-sampling algorithms included 
Random Under-sampling, Cluster Centroids Under-sampling 
(CC), Random Over-sampling, Synthetic Minority Over-
sampling (SMOTE) and combination sampling (SME). The 
model performances with selected re-sampling methods were 
shown in Table 1. 
Generally speaking, SMOTE outperformed the other re-
sampling methods. With data re-sampled by SMOTE, a 
Gradient Boosting model could achieve a log-loss of .21 and 
an AUC score of .83.  Compared to the baseline models, the 
model performance was improved significantly by re-sampling. 
Cross-validation was then conducted to tun hyper-parametes 
and to validate the model performance. The mean ROC curve 
after 5 fold cross-validation was shown in Figure 1.
Re-sampling Techniques
As shown in Figure 2., the model had achieve an accuracy of 93%. It 
performed well in predicting non-necrosis but it still need to be 
improved to identify necrosis patients. 
As suggested by the important features of the model, one possible 
reason of the vague prediction on necrosis was lacking important 
information about each metastasis. Current available data was only 
patient-level. Next step of this project will be collecting metastasis-
level data , exploring weighted techniques to handle unbalanced data 
and then generating suggested radiotherapy dose value for 
metastases treatment.
Discussion and Conclusions
Logistics 
Regression
Random Forest Gradient Boosting
Under-sampling .90 (.72) .65 (.81) .67 (.79)
CC .63 (.78) 9.83 (.63) .69 (.72)
SMOTE .49 (.80) .38 (.82) .21 (.83)
SME .71 (.79) .71 (.80) .33 (.80)
Models Exploration
Table 1. Model Performances - Log-loss (AUC).
Brain metastases, or secondary  brain tumors are cancer cells 
that spread from their original site to the brain. They are the 
most common malignancy occurring within the cranium. In 
America, about 25% of cancer patients suffered from 
secondary brain tumors [1]. 
Treatment of brain metastases is multidisciplinary with 
radiation forming the cornerstone[2]. However, significant risks 
are accompanied by radiation therapy. 
Cerebral necrosis, which is one of these, is the unnatural death 
of  the cells in an organ or tissue surrounding the tumor. Given 
that its characteristics on standard imaging are no different 
that tumor recurrence, traditional diagnosis of necrosis is 
time-consuming and challenging. 
The goal of this project is to leverage the plentiful information 
of patient data to identify the patients with a higher risk for 
radiation necrosis, and consequently lead to more effective 
treatment strategies for brain metastases patients. 
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Figure 1. Mean ROC curve of SMOTE Model. Figure 2. Confusion Matrix of SMOTE Model .
